485-P: Insights from Type 2 Diabetes Patients Reveal Education- and Income-Based Disparities in Awareness Surrounding Kidney Disease Risk and Renoprotective Therapies

Objective: Diabetes is a leading cause of chronic kidney disease (CKD), and new drug classes including SGLT-2 inhibitors and GLP-1 receptor agonists have shown renal benefits for those with type 2 diabetes (T2D). This study evaluated T2D patients’ awareness regarding CKD and renoprotective drugs acr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2021-06, Vol.70 (Supplement_1)
Hauptverfasser:	STEVENSON, JULIA, YE, EMILY, SUHL, SARA, GOWEN, REBECCA, TAIT, JACQUELINE, FLORISSI, CATERINA, WOOD, RICHARD
Format:	Artikel
Sprache:	eng
Schlagworte:	Diabetes Diabetes mellitus (non-insulin dependent) Drugs Education GLP-1 receptor agonists Kidney diseases Secondary schools
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!